Results 181 to 190 of about 3,193,060 (260)

Outcomes and Trends of Anal Squamous Cell Carcinoma in Queensland: A 26‐Year Review

open access: yesANZ Journal of Surgery, EarlyView.
Anal squamous cell carcinoma incidence and mortality increased substantially in Queensland over 26 years, while survival outcomes remained unchanged. Evolving HPV prevention and screening strategies offer opportunities to reduce future disease burden, but substantial implementation barriers exist.
Amanda G. Liesegang   +3 more
wiley   +1 more source

Vertical Rectus Abdominis Myocutaneous Flap Reduces Pelvic Exenteration Morbidity: A Retrospective Single‐Centre Cohort Study

open access: yesANZ Journal of Surgery, EarlyView.
ABSTRACT Background Pelvic exenteration (PE) has emerged as a viable resection strategy for locally advanced and recurrent pelvic cancers; however, it carries the burden of significant morbidity. The vertical rectus abdominis myocutaneous (VRAM) flap is a reconstructive method designed to minimise postoperative wound complications, and this study ...
Bernard Hanekom   +4 more
wiley   +1 more source

Prognostic factors for lymph node infestation, long-term survival and recurrence rates in patients with vaginal cancer: a population-based study in Germany. [PDF]

open access: yesJ Cancer Res Clin Oncol
Wenning S   +17 more
europepmc   +1 more source

Quality‐of‐life and late effects after transabdominal cerclage: A nationwide matched cohort study

open access: yesActa Obstetricia et Gynecologica Scandinavica, EarlyView.
Permanent transabdominal cerclage does not appear to be associated with impaired quality‐of‐life or persistent late effects when compared to women without cerclage, regardless of mode of birth. These findings provide a more evidence‐based foundation for counseling when considering transabdominal cerclage for the prevention of preterm birth.
Lea Kirstine Hansen   +6 more
wiley   +1 more source

Silicon dioxide vaginal gel and short‐term high‐risk human papillomavirus DNA detectability: A randomized controlled trial

open access: yesActa Obstetricia et Gynecologica Scandinavica, EarlyView.
In an independent randomized trial of 242 women with PCR‐confirmed hrHPV infection, 3 months of silicon dioxide‐based vaginal gel did not improve hrHPV DNA non‐detectability compared with observation alone (18% vs. 21%). Patient‐reported adverse events were more frequent with gel (32% vs. 2%), and overall patient satisfaction was lower.
Julia M. Hecken   +4 more
wiley   +1 more source

Primary vaginal cancer treated with high-dose rate brachytherapy and intraprocedural magnetic resonance imaging. [PDF]

open access: yesBrachytherapy
Gardner UG   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy